Obesity in America was a pervasive issue even before COVID-19 took hold. However, the pandemic lifestyle of staying home more and moving around less, has meant weight gain for many. A survey of several thousand people by the American Psychological Association (APA) showed that 42 percent reported gaining weight during the pandemic – an average of 29 pounds.1
Encouragingly, weight-loss medications have become more effective. Along with counseling and digital tools, support is available wherever and whenever people are ready to embrace them. For clients, this can mean a healthier, more productive workforce and help to prevent the progression of chronic conditions among their members.2
To offer further support for our customers who struggle with weight gain, SafeGuardRx for Cigna – a program that helps drive down client costs for many complex, costly conditions – will include a weight management program, effective April 1, 2022.
Client eligibility for the SafeGuardRx for Cigna Weight Management Program is vast, but some exceptions apply.
The SafeGuardRx for Cigna Weight Management Program automatically applies to all Cigna pharmacy commercial clients that have elected or purchased weight loss coverage/buy-up coverage (for diet drugs & anti-obesity). These clients are automatically enrolled – with no additional action or cost to clients required. Exceptions may apply to pharmacy clients in standalone plans.
The SafeGuardRx for Cigna Weight Management Program supports customers who may be eligible according to these considerations:
Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, review your plan documents or contact a Cigna representative.
All Cigna products and service are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Evernorth Care Solutions, Inc., Evernorth Behavioral Health, Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.
© 2022 Cigna. All rights reserved